FACTORS AFFECTING THE MAINTENANCE DOSE OF WARFARIN

被引:143
|
作者
JAMES, AH
BRITT, RP
RASKINO, CL
THOMPSON, SG
机构
[1] HILLINGDON HOSP,DEPT HAEMATOL,UXBRIDGE UB8 3NN,MIDDX,ENGLAND
[2] UNIV LONDON LONDON SCH HYG & TROP MED,MED STAT UNIT,LONDON WC1E 7HT,ENGLAND
关键词
D O I
10.1136/jcp.45.8.704
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: To identify the possible factors determining the dose of warfarin prescribed in patients receiving anticoagulant treatment. Methods: The computerised records of 2305 patients maintained on the drug in seven hospitals were amalgamated and classified into one of seven diagnostic groups. The associations with the dose of warfarin prescribed were investigated by univariate and multiple regression analysis. Differences between hospitals were studied with regard to the coagulometric method and the thromboplastin preparation used. Results: The geometric mean dose of warfarin was 4.57 mg and 5% of patients were prescribed 10 mg or greater. There was a noticeable decrease in dose with increasing age, which averaged about 6 mg for patients aged 30 but 3.5 mg for those aged 80. Men required slightly more warfarin than women. Patients with heart disease or atrial fibrillation required lower doses of warfarin, while higher doses were required by patients with deep vein thrombosis. Significant differences in mean warfarin dose among the seven hospitals were evident. These differences could not be explained entirely by the use of different coagulometric methods or thromboplastins. Conclusion: Clinicians should be aware that older patients need reduced doses of warfarin. The considerable differences in doses of warfarin among hospitals indicates that further efforts to improve uniformity are required.
引用
收藏
页码:704 / 706
页数:3
相关论文
共 50 条
  • [41] Influence of Vitamin D Status on the Maintenance Dose of Warfarin in Patients Receiving Chronic Warfarin Therapy
    Nakisa Khansari
    Maryam Bagheri
    Shahram Homayounfar
    Jalal Poorolajal
    Maryam Mehrpooya
    Cardiology and Therapy, 2022, 11 : 421 - 432
  • [42] Performance Evaluation of Warfarin Dose Prediction Algorithms and Effects of Clinical Factors on Warfarin Dose in Chinese Patients
    Gao, Weiqi
    Li, Zhihong
    Chen, Weihong
    Zhang, Shuqiu
    THERAPEUTIC DRUG MONITORING, 2021, 43 (04) : 527 - 535
  • [43] Clinical and genetic factors associated with warfarin maintenance dose in northern Chinese patients with mechanical heart valve replacement
    Liu, Rui
    Cao, Jian
    Zhang, Qian
    Shi, Xin-Miao
    Pan, Xiao-Dong
    Dong, Ran
    MEDICINE, 2017, 96 (02)
  • [44] A formula for predicting the maintenance dose of warfarin in patients started on a daily 5 mg dose
    Dobrzanski, S.
    Begum, S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2009, 145 : 35 - 35
  • [45] STANDARDIZED INITIAL WARFARIN TREATMENT - EVALUATION OF INITIAL TREATMENT RESPONSE AND MAINTENANCE DOSE PREDICTION BY RANDOMIZED TRIAL, AND RISK-FACTORS FOR AN EXCESSIVE WARFARIN RESPONSE
    DOECKE, CJ
    COSH, DG
    GALLUS, AS
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1991, 21 (03): : 319 - 324
  • [46] Performance of commercial platforms for rapid genotyping of polymorphisms affecting warfarin dose
    King, Cristi R.
    Porche-Sorbet, Rhonda M.
    Gage, Brian F.
    Ridker, Paul M.
    Renaud, Yannick
    Phillips, Michael S.
    Eby, Charles
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2008, 129 (06) : 876 - 883
  • [47] Assessment of factors affecting mortality in geriatric patients with warfarin overdose
    Dagar, Seda
    Emektar, Emine
    Uzunosmanoglu, Hueseyin
    Cevik, Yunsur
    TURKISH JOURNAL OF EMERGENCY MEDICINE, 2020, 20 (04): : 180 - 185
  • [48] Pharmacogentic factors affecting INR control during warfarin initiation
    Eby, Charles S.
    Harris, Jenine K.
    Gage, Brian F.
    Ridker, Paul M.
    Goldhaber, Samuel Z.
    Birman-Deych, Elena
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2008, 25 (01) : 98 - 98
  • [49] Factors affecting warfarin therapy following cardiac valve surgery
    Lee, J
    Lee, B
    Kim, K
    Ahn, H
    Suh, O
    Lee, M
    Shin, W
    ANNALS OF PHARMACOTHERAPY, 2002, 36 (12) : 1845 - 1850
  • [50] Pharmacogentic factors affecting INR control during warfarin initiation
    Charles S. Eby
    Jenine K. Harris
    Brian F. Gage
    Paul M. Ridker
    Samuel Z. Goldhaber
    Elena Birman-Deych
    Journal of Thrombosis and Thrombolysis, 2008, 25 : 98 - 98